Cancer News and Research

Latest Cancer News and Research

Varian Medical Systems to showcase radiotherapy and radiosurgery solutions at medical events in Asia

Varian Medical Systems, Inc., the world's leading manufacturer of medical technology for treating cancer with radiotherapy and radiosurgery, will showcase its technology at two medical events in Asia during the month of March:

18 Mar 2010

CCAC launches online campaign to raise colorectal screening awareness

As part of its March awareness month kick off, the Colorectal Cancer Association of Canada has launched a unique campaign to encourage Canadian men and women to show their butts online so as to raise awareness about the importance of getting screened for colorectal cancer.

18 Mar 2010

Reversal of aging shown in human stem cells

A team of North American collaborators from both industrial research centers (Biotime Inc, Mandala Biosciences LLC and Sierra Sciences LLC) and academic institutes (Ontario Cancer Institute, Burnham Institute for Medical Research and The Scripps Research Institute) have demonstrated successful reversal of the developmental aging of normal human cells.

18 Mar 2010

Palliative care continues to play vital role in the continuum of cancer care: Study

A study from The University of Texas M. D. Anderson Cancer Center reports that cancer centers in the United States provide patients and their families with palliative care, though the depth, range and integration of programs and services widely vary.

18 Mar 2010

New chemotherapeutic agents for colorectal cancer: High-cost/low-value medical care

New chemotherapy agents appear associated with improvements in survival time for patients with metastastic colorectal cancer, but at substantial cost, according to a report in the March 22 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

18 Mar 2010

Bavarian Nordic completes last step to support use of IMVAMUNE, receives FDA notification

Bavarian Nordic A/S announced today that it has received notification that the U.S. Food and Drug Administration (FDA) has accepted all the actions taken by the company to address the observations made during the inspection of the manufacturing facilities in 2009. This was the last step along with the clinical and preclinical data that will be used to potentially support the use of IMVAMUNE® following a declared emergency.

18 Mar 2010

Genes allowing opium poppy to make codeine and morphine discovered

Researchers at the University of Calgary have discovered the unique genes that allow the opium poppy to make codeine and morphine, thus opening doors to alternate methods of producing these effective painkillers either by manufacturing them in a lab or controlling the production of these compounds in the plant.

18 Mar 2010

EDP Biotech briefs Tennessee state legislators on ColoMarker colon cancer test

EDP Biotech, a Knoxville-based company today briefed Tennessee state legislators on its revolutionary ColoMarker™ colon cancer test which potentially could save 50,000 lives and more than $12 billion in healthcare costs annually in the U.S. Legislators were also provided the opportunity to personally experience the ColoMarker™ test by enrolling in the control study group for EDP’s latest research.

18 Mar 2010

NexACT technology demonstrates ability to deliver Taxol subcutaneously

NexMed, Inc., a specialty CRO and a developer of products based on the NexACT® technology, today announced that pre-clinical results from the research and development group at its Bio-Quant subsidiary have successfully demonstrated the ability of the NexACT technology to deliver insulin and other large molecule drugs such as Taxol subcutaneously, in a depot-like fashion (or slow release) over a 24 hour period from a single injection.

18 Mar 2010

Combination of gemcitabine and cisplatin limits the progression of endometrial cancer: Study

Researchers from The University of Texas M. D. Anderson Cancer Center report that in a small study of women with advanced or recurrent endometrial cancer, gemcitabine and cisplatin, when used in combination, produced a response rate in fifty percent of patients.

18 Mar 2010

Prometheus Laboratories, Bayer Schering Pharma form research collaboration and license agreement

Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, today announced the execution of a research collaboration and license agreement with Bayer Schering Pharma AG, Germany, a worldwide leading specialty pharmaceutical company. The collaboration partners Prometheus' proprietary oncology diagnostic platform with Bayer's broad oncology pipeline in an effort to stratify patients to appropriate drug candidates and potentially accelerate the development of novel oncology therapeutic products.

18 Mar 2010

Medtronic's Advisa DR MRI SureScan pacemaker commercially available in selected European geographies

Medtronic, Inc. announced today the commercial availability of the Advisa DR MRI™ SureScan™ pacemaker in selected European geographies. The Advisa DR MRI SureScan pacemaker is the company’s second-generation pacemaker in a portfolio of devices from Medtronic designed, tested, and approved for use as labeled with MRI machines in selected European geographies.

18 Mar 2010

New campaign invites people share their journeys through Ontario's health care system

Ontario's doctors are giving a voice to patients across the province with their latest public awareness campaign. The campaign features real people sharing their journeys through Ontario's health care system and highlights the unique relationship between patients and their doctors.

18 Mar 2010

Bone marrow stem cells offer potential treatment for patients with peripheral arterial disease

Bone marrow stem cells suspended in X-ray-visible microbubbles dramatically improve the body's ability to build new blood vessels in the upper leg-providing a potential future treatment for those with peripheral arterial disease or PAD, say researchers at the Society of Interventional Radiology's 35th Annual Scientific Meeting in Tampa, Fla.

18 Mar 2010

Standardized skin-care guidelines

Given the complexity of cancer treatment, skin care may seem like a small matter. However, a nurse at the James P. Wilmot Cancer Center knew that skin issues were a constant source of anxiety for many patients receiving radiation therapy, and through research she discovered that routine advice was rooted in myth instead of scientific evidence.

18 Mar 2010

LSUHSC: Differences in drug metabolism can lead to differences in the effectiveness of candidate drug

Research led by Wayne L. Backes, PhD, Professor of Pharmacology and Associate Dean for Research at LSU Health Sciences Center New Orleans School of Medicine, has found that drug metabolism depends not only upon which enzymes are present in an individual, but also how they interact, and that can be the difference in whether a drug is safely eliminated from the body or is converted into a toxic or carcinogenic byproduct.

18 Mar 2010

Early baldness may not be associated with risk of prostate cancer

Men who start losing their hair at an early age may be less likely to develop prostate cancer in the future, new research suggests.

18 Mar 2010

SBRT can improve survival rates for patients with inoperable non-small cell lung cancer

Highly-focused stereotactic body radiation therapy (SBRT) can eliminate the targeted tumor while avoiding treatment-related illness and may ultimately improve survival for patients with inoperable non-small cell lung cancer, according to early findings of a Radiation Therapy Oncology Group study published in the March 17 cancer-themed issue of the Journal of the American Medical Association.

18 Mar 2010

iVillage launches new Health site to help women manage their health needs online

iVillage today announced the launch of its new Health site (www.ivillage.com/Health), the first women's destination on the Web that combines medical expertise and original health content with community conversations and interactive tools, to help women manage their health needs online.

18 Mar 2010

Adjuvant chemotherapy may benefit older patients with stage III colon cancer

Even though older patients with colon cancer are less likely to receive chemotherapy following surgery because of concerns of adverse events, new research indicates that when they do receive this treatment, it is less toxic and of shorter duration than therapy younger patients receive, and older patients experience fewer adverse events, according to a study in the March 17 issue of JAMA, a theme issue on cancer.

18 Mar 2010

Cancer News and Research

Latest Cancer News and Research

Varian Medical Systems to showcase radiotherapy and radiosurgery solutions at medical events in Asia

CCAC launches online campaign to raise colorectal screening awareness

Reversal of aging shown in human stem cells

Palliative care continues to play vital role in the continuum of cancer care: Study

New chemotherapeutic agents for colorectal cancer: High-cost/low-value medical care

Bavarian Nordic completes last step to support use of IMVAMUNE, receives FDA notification

Genes allowing opium poppy to make codeine and morphine discovered

EDP Biotech briefs Tennessee state legislators on ColoMarker colon cancer test

NexACT technology demonstrates ability to deliver Taxol subcutaneously

Combination of gemcitabine and cisplatin limits the progression of endometrial cancer: Study

Prometheus Laboratories, Bayer Schering Pharma form research collaboration and license agreement

Medtronic's Advisa DR MRI SureScan pacemaker commercially available in selected European geographies

New campaign invites people share their journeys through Ontario's health care system

Bone marrow stem cells offer potential treatment for patients with peripheral arterial disease

Standardized skin-care guidelines

LSUHSC: Differences in drug metabolism can lead to differences in the effectiveness of candidate drug

Early baldness may not be associated with risk of prostate cancer

SBRT can improve survival rates for patients with inoperable non-small cell lung cancer

iVillage launches new Health site to help women manage their health needs online

Adjuvant chemotherapy may benefit older patients with stage III colon cancer

Understanding the DNA Damage Response in Innate Immunity eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in